Target intelligence / Profile preview

T cell receptor alpha variable 13-1 (TRAV13-1)

Target
TRAV13-1
Molecular classification
Immunoglobulin superfamily protein (IgSF), Variable region gene segment (T cell receptor gene family), Other (Gene for antigen receptor subunit)
01

Overview

T cell receptor alpha variable 13-1 (TRAV13-1) is a gene segment encoding one of the numerous variable (V) regions for the alpha chain of the T cell receptor (TCR), an essential component of the adaptive immune system. The TCR alpha chain is generated by somatic recombination of V (variable), J (joining), and C (constant) gene segments. TRAV13-1 contributes to antigen recognition diversity when it combines with specific J and C segments to form the TCRα chain, which pairs with a TCRβ chain to create a unique TCR heterodimer displayed on T cell surfaces. TCRs containing the TRAV13-1 segment recognize peptides bound to major histocompatibility complex (MHC) molecules, leading to T cell activation and adaptive immune responses. While the T cell receptor as a complex is a major focus for immunotherapies (such as engineered TCR-T cells), individual V gene segments like TRAV13-1 are mainly of interest in immunological research and biomarker development for repertoire tracking and clonal analysis.

Other names
TRAV13-1TRAV131TCRAV8S1TCRAV13S1
02

Mechanism of action

None (drugs acting at the level of individual variable gene segments are not established; mechanisms relate to T cell receptor-ligand recognition and downstream immunomodulation)

03

Biological functions

Antigen recognition as part of the T cell receptor complexAdaptive immune response mediationSignal transduction via T cell receptor when assembled into full TCR complexT cell activation
04

Disease associations

Other (TRAV13-1 itself does not have specific direct disease roles but as part of the TCR repertoire, it contributes to immune responses in cancer, autoimmunity, infection, and transplant rejection)
05

Safety considerations

None specific to TRAV13-1 (engineered TCR therapies in general can have risks like cytokine release syndrome, off-target effects, or autoimmunity, but these relate to the engineered receptor complex, not an individual gene segment)
06

Interacting drugs

None (no drugs directly target TRAV13-1 or individual TCR V alpha gene segments; drugs may target T cells or engineered TCRs as a whole)
07

Biomarkers

TCR variable region genes, including TRAV13-1, can be used as biomarkers for T cell clonality or tracking T cell responses in certain contexts (e.g., minimal residual disease in leukemia, monitoring TCR repertoire after immunotherapy)

Beyond the preview

Go deeper on T cell receptor alpha variable 13-1 (TRAV13-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 13-1 (TRAV13-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call